1.Predicting Responsiveness to Biofeedback Therapy Using High-resolution Anorectal Manometry With Integrated Pressurized Volume
Myeongsook SEO ; Jiyoung YOON ; Kee Wook JUNG ; Segyeong JOO ; Jungbok LEE ; Kyung Min CHOI ; Hyo Jeong LEE ; In Ja YOON ; Woojoo NOH ; So Young SEO ; Do Yeon KIM ; Sung Wook HWANG ; Sang Hyoung PARK ; Dong-Hoon YANG ; Byong Duk YE ; Jeong-Sik BYEON ; Suk-Kyun YANG ; Seung-Jae MYUNG
Journal of Neurogastroenterology and Motility 2022;28(4):608-617
Background/Aims:
Biofeedback therapy is widely used to treat patients with chronic constipation, especially those with dyssynergic defecation. Yet, the utility of high-resolution manometry with novel parameters in the prediction of biofeedback response has not been reported. Thus, we constructed a model for predicting biofeedback therapy responders by applying the concept of integrated pressurized volume in patients undergoing high-resolution anorectal manometry.
Methods:
Seventy-one female patients (age: 48-68 years) with dyssynergic defecation who underwent initial high-resolution anorectal manometry and subsequent biofeedback therapy were enrolled. The manometry profiles were used to calculate the 3-dimensional integrated pressurized volumes by multiplying the distance, time, and amplitude during simulated evacuation. Partial least squares regression was performed to generate a predictive model for responders to biofeedback therapy by using the integrated pressurized volume parameters.
Results:
Fifty-five (77.5%) patients responded to biofeedback therapy. The responders and non-responders did not show significant differences in the conventional manometric parameters. The partial least squares regression model used a linear combination of eight integrated pressurized volume parameters and generated an area under the curve of 0.84 (95% confidence interval: 0.76-0.95, P < 0.01), with 85.5% sensitivity and 62.1% specificity.
Conclusions
Integrated pressurized volume parameters were better than conventional parameters in predicting the responsiveness to biofeedback therapy, and the combination of these parameters and partial least squares regression was particularly promising. Integrated pressurized volume parameters can more effectively explain the physiology of the anorectal canal compared with conventional parameters.
2.Colonic Pseudo-obstruction With Transition Zone: A Peculiar Eastern Severe Dysmotility
Eun Mi SONG ; Jong Wook KIM ; Sun Ho LEE ; Kiju CHANG ; Sung Wook HWANG ; Sang Hyoung PARK ; Dong Hoon YANG ; Kee Wook JUNG ; Byong Duk YE ; Jeong Sik BYEON ; Suk Kyun YANG ; Hyo Jeong LEE ; Chang Sik YU ; Chan Wook KIM ; Seong Ho PARK ; Jihun KIM ; Seung Jae MYUNG
Journal of Neurogastroenterology and Motility 2019;25(1):137-147
BACKGROUND/AIMS: Previous studies from Korea have described chronic intestinal pseudo-obstruction (CIPO) patients with transition zone (TZ) in the colon. In this study, we evaluated the pathological characteristics and their association with long-term outcomes in Korean colonic pseudo-obstruction (CPO) patients with TZ. METHODS: We enrolled 39 CPO patients who were refractory to medical treatment and underwent colectomy between November 1989 and April 2016 (median age at symptoms onset: 45 [interquartile range, 29–57] years, males 46.2%). The TZ was defined as a colonic segment connecting a proximally dilated and distally non-dilated segment. Detailed pathologic analysis was performed. RESULTS: Among the 39 patients, 37 (94.9%) presented with TZ and 2 (5.1%) showed no definitive TZ. Median ganglion cell density in the TZ adjusted for the colonic circumference was significantly decreased compared to that in proximal dilated and distal non-dilated segments in TZ (+) patients (9.2 vs 254.3 and 150.5, P < 0.001). Among the TZ (+) patients, 6 showed additional pathologic findings including eosinophilic ganglionitis (n = 2), ulcers with combined cytomegalovirus infection (n = 2), diffuse ischemic changes (n = 1), and heterotropic myenteric plexus (n = 1). During follow-up (median, 61 months), 32 (82.1%) TZ (+) patients recovered without symptom recurrence after surgery. The presence of pathological features other than hypoganglionosis was an independent predictor of symptom recurrence after surgery (P = 0.046). CONCLUSIONS: Hypoganglionosis can be identified in the TZ of most Korean CPO patients. Detection of other pathological features in addition to TZ-associated hypoganglionosis was associated with poor post-operative outcomes.
Cell Count
;
Colectomy
;
Colon
;
Colonic Pseudo-Obstruction
;
Cytomegalovirus Infections
;
Eosinophils
;
Follow-Up Studies
;
Ganglion Cysts
;
Humans
;
Intestinal Pseudo-Obstruction
;
Korea
;
Male
;
Myenteric Plexus
;
Pathology
;
Recurrence
;
Ulcer
3.Prevalence of Fructose Malabsorption in Patients With Irritable Bowel Syndrome After Excluding Small Intestinal Bacterial Overgrowth
Kee Wook JUNG ; Myeognsook SEO ; Young Hwan CHO ; Young Ok PARK ; So Yoon YOON ; Jungbok LEE ; Dong Hoon YANG ; In Ja YOON ; So Young SEO ; Hyo Jeong LEE ; Sang Hyoung PARK ; Kyung Jo KIM ; Byong Duk YE ; Jeong Sik BYEON ; Hwoon Yong JUNG ; Suk Kyun YANG ; Jin Ho KIM ; Seung Jae MYUNG
Journal of Neurogastroenterology and Motility 2018;24(2):307-316
BACKGROUND/AIMS: Fructose malabsorption (FM) mimics symptoms of irritable bowel syndrome (IBS), and its prevalence has increased. Diagnosing FM in IBS is challenging because of its overlap with small intestinal bacterial overgrowth (SIBO). We assessed the prevalence of FM by comparing patients with IBS with asymptomatic control individuals after excluding SIBO using the glucose hydrogen breath test (HBT). METHODS: Patients diagnosed with IBS and asymptomatic control individuals were enrolled prospectively. Dietary habits were assessed with the Food Frequency Questionnaire. After excluding SIBO, participants underwent HBTs with both 15 g and 25 g of fructose. RESULTS: Thirty-five patients with IBS and 35 age- and sex-matched asymptomatic control individuals were enrolled. The 15-g fructose HBT yielded positive results in 7 of the 35 (20.0%) patients with IBS and in 2 of 35 (5.7%) controls (P = 0.070). The 25-g fructose HBT was positive in 16 of the 35 (45.7%) patients with IBS and in 8 of the 35 (22.9%) controls (P = 0.040). Analysis of the Food Frequency Questionnaire responses showed no significant differences between the 2 groups in dietary intake, although patients with IBS showed a significantly higher mean fiber intake than controls (21.24 ± 11.35 g vs 15.87 ± 7.07 g, respectively, P = 0.040). CONCLUSIONS: The 25-g fructose HBT identified FM in a significantly higher percentage of SIBO-negative patients with IBS than in asymptomatic control individuals, suggesting that FM may correlate with IBS. Education regarding dietary control of foods containing fructose may be useful for the management of patients with IBS.
Breath Tests
;
Education
;
Food Habits
;
Fructose
;
Glucose
;
Humans
;
Hydrogen
;
Irritable Bowel Syndrome
;
Prevalence
;
Prospective Studies
4.Relation of Enteric α-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson's Disease and in Neurologically Intact Subjects
Hyo Jeong LEE ; Kee Wook JUNG ; Sun Ju CHUNG ; Seung Mo HONG ; Juyeon KIM ; Jeong Hoon LEE ; Sung Wook HWANG ; Ho Sung RYU ; Mi Jung KIM ; Ho Su LEE ; Myeongsook SEO ; Sang Hyoung PARK ; Dong Hoon YANG ; Byong Duk YE ; Jeong Sik BYEON ; Jaewon CHOE ; Hwoon Yong JUNG ; Suk Kyun YANG ; Seung Jae MYUNG
Journal of Neurogastroenterology and Motility 2018;24(3):469-478
BACKGROUND/AIMS: α-Synucleinopathy in the brain is the neuropathological hallmark of Parkinson’s disease (PD). However, the functional impact of α-synucleinopathy in the enteric nervous system remains unknown. We aim to evaluate the association between gastrointestinal (GI) dysfunction and α-synuclein (αSYN) pathology in the stomach and colon of PD patients and controls, as well as to investigate the association between the αSYN pathology in GI tract and future PD risk. METHODS: A total of 35 PD patients and 52 neurologically intact subjects were enrolled in this study. Endoscopic biopsies were performed, and then immunohistochemical staining for αSYN was performed. All subjects completed the validated Rome III questionnaire for the assessment of GI symptoms. The association between GI symptoms and the αSYN pathology in GI mucosa was evaluated. Incident PD cases were assessed during a median follow-up of 46 months. RESULTS: The proportion of self-reported constipation and functional constipation through the Rome III questionnaire was significantly higher in PD patients than in controls (P < 0.001 and P = 0.015). However, no significant association was found between the αSYN pathology in the stomach and colon mucosa and constipation, as well as other GI symptoms including dyspepsia symptoms and abdominal discomfort or pain, regardless of the presence or absence of clinical PD (P > 0.05). No incident PD cases were diagnosed during study period. CONCLUSIONS: Our present study suggests that the deposition of αSYN in the mucosal enteric nervous system may not be reflected by functional impairment of the affected segment of the gut.
Biopsy
;
Brain
;
Colon
;
Constipation
;
Dyspepsia
;
Enteric Nervous System
;
Follow-Up Studies
;
Gastrointestinal Tract
;
Humans
;
Mucous Membrane
;
Parkinson Disease
;
Pathology
;
Stomach
5.Epicardial Fat Thickness is Correlated with Vagal Hyperactivity in Patients with Neurally-Mediated Syncope.
Kyoung Im CHO ; Young Soo LEE ; Byong Kyu KIM ; Bong Joon KIM ; Kee Sik KIM
Journal of Cardiovascular Ultrasound 2017;25(2):57-62
BACKGROUND: Epicardial fat tissue has unique endocrine and paracrine functions that affect the cardiac autonomic system. The head-up tilt test (HUTT) is a simple non-invasive measurement that assesses autonomic nervous system dysfunction. We investigated the association between epicardial fat thickness (EFT) and autonomic neural tone, such as vagal tone. METHODS: A total of 797 consecutive patients (mean age 46.5 years, male: 45.7%) who underwent HUTT and echocardiography between March 2006 and June 2015 were enrolled. EFT was measured during the diastolic phase of the parasternal long axis view. We excluded patients with prior percutaneous coronary intervention, old age (* 70 years old), valvular heart disease, symptomatic arrhythmias and diabetes. We divided patients into two groups based on the HUTT (positive vs. negative). RESULTS: There were 329 patients (41.3%) with a negative HUTT result and 468 patients (58.7%) with a positive result. The HUTT-positive patients showed a significantly lower waist circumference, body mass index and systolic and diastolic blood pressure, although a significantly higher EFT as compared to the HUTT-negative patients (HUTT-positive, 5.69 ± 1.76 mm vs. HUTT-negative, 5.24 ± 1.60 mm; p < 0.001). EFT > 5.4 mm was associated with a positive HUTT result with 51.7% sensitivity and 63.8% specificity (p < 0.001) on receiving operator characteristic analysis. Multivariate Cox regression analysis revealed that EFT (hazard ratio: 1.02, 95% confidence interval: 1.01–1.30, p = 0.004) was an independent predictor of HUTT-positivity. CONCLSION: EFT was significantly correlated with positive HUTT, which suggests an association between EFT and autonomic dysregulation.
Arrhythmias, Cardiac
;
Autonomic Nervous System
;
Blood Pressure
;
Body Mass Index
;
Echocardiography
;
Heart Valve Diseases
;
Humans
;
Male
;
Percutaneous Coronary Intervention
;
Sensitivity and Specificity
;
Syncope*
;
Syncope, Vasovagal
;
Waist Circumference
6.Usefulness of C-Reactive Protein as a Disease Activity Marker in Crohn's Disease according to the Location of Disease.
Dong Hoon YANG ; Suk Kyun YANG ; Sang Hyoung PARK ; Ho Su LEE ; Sun Jin BOO ; Jae Ho PARK ; Soo Young NA ; Kee Wook JUNG ; Kyung Jo KIM ; Byong Duk YE ; Jeong Sik BYEON ; Seung Jae MYUNG ; Jin Ho KIM
Gut and Liver 2015;9(1):80-86
BACKGROUND/AIMS: C-reactive protein (CRP) is a serologic activity marker in Crohn's disease (CD), but it may be less useful in evaluating CD activity in ileal CD patients. We aimed to investigate the usefulness of CRP as a disease activity marker in CD according to disease location. METHODS: Korean CD patients in a single hospital were evaluated. Factors associated with elevated CRP concentration at the time of diagnosis of CD and the association between the physician's prediction regarding upcoming surgery and the sites of the lesions directly related to surgery were analyzed. RESULTS: Of 435 CD patients, 25.7%, 6.9%, and 67.4% had ileal, colonic, and ileocolonic CD, respectively. Multivariate analysis revealed that an elevated erythrocyte sedimentation rate, reduced serum albumin, CD activity index (CDAI) >220, and ileocolonic/colonic location were associated with an elevated CRP level and that the CRP level was significantly correlated with the CDAI in all CD patients (gamma=0.466, p<0.01). However, the correlation coefficient was dependent on the location, with values of 0.395, 0.456, and 0.527 in patients with an ileal, ileocolonic, and colonic disease location, respectively. Surgery for ileal lesions was less predictable than surgery for ileocolonic or colonic lesions during follow-up. CONCLUSIONS: CRP is less useful as a disease activity marker in patients with ileal CD than those with ileocolonic or colonic CD.
Adolescent
;
Adult
;
Aged
;
Biological Markers/blood
;
Blood Sedimentation
;
C-Reactive Protein/*analysis
;
Child
;
Colon/pathology
;
Crohn Disease/blood/*diagnosis/pathology
;
Female
;
Humans
;
Ileum/pathology
;
Male
;
Middle Aged
;
Serum Albumin/analysis
;
Severity of Illness Index
;
Young Adult
7.Postpolypectomy Fever, a Rare Adverse Event of Polypectomy: Nested Case-Control Study.
Seung Hoon LEE ; Kyung Jo KIM ; Dong Hoon YANG ; Kee Wook JEONG ; Byong Duk YE ; Jeong Sik BYEON ; Seung Jae MYUNG ; Suk Kyun YANG ; Jin Ho KIM
Clinical Endoscopy 2014;47(3):236-241
BACKGROUND/AIMS: Although postpolypectomy fever (PPF) without colon perforation or hemorrhage is rare, its incidence and risk factors have not been investigated. The objective of this study was to analyze the incidence and risk factors for PPF among inpatients. METHODS: Seven patients with PPF were matched with 70 patients without PPF from a total of 3,444 patients who underwent colonoscopic polypectomy. The PPF incidence during index hospitalization after colonoscopy was calculated, and univariate and multivariate analyses were performed to calculate the adjusted odds ratios (ORs) for risk factors. RESULTS: PPF without bleeding or perforation in the colon occurred in seven patients (0.2%). The median age was 58 years for cases and 61 years for controls. The median interval from polypectomy to occurrence of fever was 7 hours, and the median duration of fever was 9 hours. Polyp size >2 cm (adjusted OR, 1.08; 95% confidence interval [CI], 1.01 to 1.15; p=0.02) and hypertension (adjusted OR, 14.40; 95% CI, 1.23 to 180.87; p=0.03) were associated with a significantly increased risk of PPF. PPF increased the length of hospitalization. CONCLUSIONS: Although the crude incidence of PPF is low, PPF may prolong hospitalization. Risk factors for PPF include hypertension and large polyps.
Case-Control Studies*
;
Colon
;
Colonoscopy
;
Fever*
;
Hemorrhage
;
Hospitalization
;
Humans
;
Hypertension
;
Incidence
;
Inpatients
;
Multivariate Analysis
;
Odds Ratio
;
Polyps
;
Risk Factors
8.Electrical Stimulation Therapy in Chronic Functional Constipation: Five Years' Experience in Patients Refractory to Biofeedback Therapy and With Rectal Hyposensitivity.
Kee Wook JUNG ; Dong Hoon YANG ; In Ja YOON ; So Young SEO ; Hyun Sook KOO ; Hyo Jeong LEE ; Ho Su LEE ; Ji Beom KIM ; Jong Wook KIM ; Soo Kyung PARK ; Sang Hyoung PARK ; Kyung Jo KIM ; Byong Duk YE ; Jeong Sik BYEON ; Hwoon Yong JUNG ; Suk Kyun YANG ; Jin Ho KIM ; Seung Jae MYUNG
Journal of Neurogastroenterology and Motility 2013;19(3):366-373
BACKGROUND/AIMS: Biofeedback therapy (BFT) can be unsuccessful in constipated patients, even those with pelvic floor dysfunction. Electrical stimulation therapy (EST) has been introduced as a novel therapeutic modality in patients with chronic constipation, especially those who have rectal hyposensitivity. We evaluated the efficacy of EST based on five years' clinical experience. METHODS: From January 2002 to February 2007, 159 patients underwent EST. After exclusion of 12 drop-outs, 147 (M:F = 61:86, 49 +/- 17 years) finished all treatment sessions. Among them, 88 (M:F = 29:59, 49 +/- 17 years) were refractory to BFT without rectal hyposensitivity (RH), and 59 (M:F = 32:27, 54 +/- 17 years) were those with RH. RESULTS: The overall response to EST was 59.2% (87/147) by per-protocol analysis. In the EST-responsive group, overall satisfaction improved significantly (from 7.3 +/- 3.0 to 4.3 +/- 2.5, P < 0.05). Subgroup analysis showed that the response rate was 64.8% (57/88) in patients refractory to BFT without RH, and 50.8% (30/59) in those with RH. CONCLUSIONS: EST may have additional therapeutic efficacy in patients who are refractory to BFT. EST may also be effective in patients with RH, including restoration of rectal sensation. Therefore, EST could be considered as an alternative choice in patients refractory to BFT and with or without RH.
Biofeedback, Psychology
;
Constipation
;
Electric Stimulation
;
Electric Stimulation Therapy
;
Humans
;
Pelvic Floor
;
Sensation
9.A Case of Cronkhite-Canada Syndrome Showing Spontaneous Remission.
Dong Uk KANG ; Dong Hoon YANG ; Yunsik CHOI ; Ji Beom KIM ; Ho Su LEE ; Hyo Jeong LEE ; Sang Hyoung PARK ; Kee Wook JUNG ; Kyung Jo KIM ; Byong Duk YE ; Jeong Sik BYEON ; Seung Jae MYUNG ; Suk Kyun YANG ; Jin Ho KIM
Intestinal Research 2013;11(4):317-322
Cronkhite-Canada syndrome (CCS) is a rare, noninherited gastrointestinal polyposis syndrome associated with ectodermal changes such as alopecia, nail dystrophy, and cutaneous hyperpigmentation. The etiology and pathogenesis of CCS are not known, but diarrhea, malnutrition, gastrointestinal bleeding, and infection may occur in the affected patient; moreover, this condition could be fatal. However, previous reports have described several cases of spontaneous remission. We report a 60-year-old man who was incidentally found to have colonic polyposis, alopecia, and hypogeusia and was diagnosed to have CCS. However, this patient experienced spontaneous remission, including regrowth of body hair and alleviation of bowel inflammation, without any specific medications such as steroids, antibiotics, or proton pump inhibitors.
Ageusia
;
Alopecia
;
Anti-Bacterial Agents
;
Colon
;
Diarrhea
;
Ectoderm
;
Hair
;
Hemorrhage
;
Humans
;
Hyperpigmentation
;
Inflammation
;
Intestinal Polyposis*
;
Malnutrition
;
Middle Aged
;
Nails
;
Proton Pump Inhibitors
;
Remission, Spontaneous*
;
Steroids
10.15-Hydroxyprostaglandin Dehydrogenase in Colorectal Mucosa as a Potential Biomarker for Predicting Colorectal Neoplasms.
Hyo Jeong LEE ; Dong Hoon YANG ; Yeon Mi RYU ; Miyeoun SONG ; Ho June SONG ; Kee Wook JUNG ; Kyung Jo KIM ; Byong Duk YE ; Jeong Sik BYEON ; Eun Kyung CHOI ; Suk Kyun YANG ; Jin Ho KIM ; Seung Jae MYUNG
Journal of Korean Medical Science 2013;28(8):1154-1160
15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is downregulated during the early stages of colorectal carcinogenesis. The aim of the present study was to investigate the potential role of 15-PGDH in normal-appearing colorectal mucosa as a biomarker for predicting colorectal neoplasms. We obtained paired tumor and normal tissues from the surgical specimens of 32 sporadic colorectal cancer patients. mRNA expression of 15-PGDH was measured using a quantitative real-time PCR assay. We evaluated the association between 15-PGDH mRNA expression in normal-appearing mucosa, the presence of synchronous adenoma, and the cumulative incidence of metachronous adenoma. The relative 15-PGDH expression of normal-appearing mucosa in patients with synchronous adenoma was significantly lower than in patients without synchronous adenoma (0.71 vs 1.00, P = 0.044). The patients in the lowest tertile of 15-PGDH expression in normal-appearing mucosa were most likely to have synchronous adenoma (OR: 10.5, P = 0.024). Patients with low 15-PGDH expression in normal-appearing mucosa also demonstrated more advanced stage colorectal cancer (P = 0.045). However, there was no significant difference in the cumulative incidence of metachronous adenoma according to 15-PGDH mRNA expression in normal-appearing mucosa (P = 0.333). Hence, 15-PGDH in normal-appearing colorectal mucosa can be a useful biomarker of field effect for the prediction of sporadic synchronous neoplasms.
Aged
;
Colorectal Neoplasms/*diagnosis/enzymology/pathology
;
Down-Regulation
;
Female
;
Humans
;
Hydroxyprostaglandin Dehydrogenases/genetics/*metabolism
;
Intestinal Mucosa/*enzymology
;
Male
;
Middle Aged
;
Neoplasm Staging
;
Neoplasms, Multiple Primary/enzymology/pathology
;
Neoplasms, Second Primary/enzymology/pathology
;
Odds Ratio
;
Predictive Value of Tests
;
RNA, Messenger/metabolism
;
Real-Time Polymerase Chain Reaction
;
Risk Factors
;
Tumor Markers, Biological/*metabolism

Result Analysis
Print
Save
E-mail